Curatek Pharmaceuticals
Executive Summary
Copromotion agreement with TAP Pharmaceuticals to increase sales support for Curatek's Metro-Vaginal (metronidazole) for treatment of bacterial vaginosis is announced Nov. 18. TAP, the joint venture between Abbott Labs and Takeda Chemical, will promote the intravaginal antifungal therapy to obstetricians and gynecologists while Curatek will continue its ongoing sales and marketing program.